184 related articles for article (PubMed ID: 7882277)
1. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Kuramoto M; Yamashita J; Ogawa M
Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
[TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
Abe M; Yamashita J; Ogawa M
Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
[TBL] [Abstract][Full Text] [Related]
3. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
4. Endocrine therapy in pancreatic carcinoma.
Yamashita J; Abe M; Ogawa M
Oncology; 1998 Dec; 55 Suppl 1():17-22. PubMed ID: 9852398
[TBL] [Abstract][Full Text] [Related]
5. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
6. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.
Díaz VM; Planaguma J; Thomson TM; Reventós J; Paciucci R
Gastroenterology; 2002 Mar; 122(3):806-19. PubMed ID: 11875015
[TBL] [Abstract][Full Text] [Related]
8. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice.
Iino Y; Takai Y; Ando T; Sugamata N; Maemura M; Takeo T; Ohwada S; Morishita Y
Cancer Chemother Pharmacol; 1993; 32(5):353-8. PubMed ID: 8339385
[TBL] [Abstract][Full Text] [Related]
9. Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma.
Xue J; Yao Y; Yao Q; Tian X; Feng Y; Su H; Kong D; Cui C; Yan L; Hao C; Zhou T
Life Sci; 2020 Nov; 260():118302. PubMed ID: 32827543
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
11. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
[TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
[TBL] [Abstract][Full Text] [Related]
14. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
[TBL] [Abstract][Full Text] [Related]
15. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
Sugyo A; Tsuji AB; Sudo H; Okada M; Koizumi M; Satoh H; Kurosawa G; Kurosawa Y; Saga T
PLoS One; 2015; 10(4):e0123761. PubMed ID: 25893775
[TBL] [Abstract][Full Text] [Related]
17. [Expression of angiogenic factors in pancreatic carcinoma cell and their significance].
Yan CQ; Zhao YP
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):787-90. PubMed ID: 19615219
[TBL] [Abstract][Full Text] [Related]
18. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer].
Ohta T; Futagami F; Arakawa H; Tsukioka Y; Kitagawa H; Kayahara M; Nagakawa T; Miyazaki I
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1669-72. PubMed ID: 8886041
[TBL] [Abstract][Full Text] [Related]
20. The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate.
Sahu RP; Srivastava SK
J Natl Cancer Inst; 2009 Feb; 101(3):176-93. PubMed ID: 19176463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
